Infect Chemother.  2017 Sep;49(3):213-218. 10.3947/ic.2017.49.3.213.

Causes of HIV Drug Non-Adherence in Korea: Korea HIV/AIDS Cohort Study, 2006-2015

• Kim MJ
• Lee SA
• Chang HH
• Kim MJ
• Woo JH
• Kim SI
• Kang C
• Kee MK
• Choi JY
• Choi Y
• Choi BY
• Kim JM
• Choi JY
• Kim HY
• Song JY
• Kim SW
• Korea HIV/AIDS Cohort Study

• KMID: 2391427
• DOI: http://doi.org/10.3947/ic.2017.49.3.213

Abstract

We aimed to determine the initial adherence of HIV cohort patients to ART (antiretroviral therapy), and reasons for non-adherence. Patients who received ART at the time of enrollment in the Korea HIV/AIDS Cohort were included in this study. Treatment adherence was determined at the baseline interview by self-reported questionnaire. Eight-hundred thirty two HIV-infected patients received ART. Of these, 253 (30.4%) patients skipped ART more than once a month. The most common reason of skipping medication was "simply forgot" (60.4%).

Keyword

Human immunodeficiency virus; Cohort Study; Adherence

MeSH Terms

Cohort Studies*
HIV*
Humans
Korea*

Reference

1. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000; 133:21–30.

2. Ickovics JR, Cameron A, Zackin R, Bassett R, Chesney M, Johnson VA, Kuritzkes DR. Adult AIDS Clinical Trials Group 370 Protocol Team. Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370. Antivir Ther. 2002; 7:185–193.

3. Korean Society for AIDS. The 2015 clinical guidelines for the treatment and prevention of opportunistic infections in HIV-infected Koreans: guidelines for opportunistic infections. Infect Chemother. 2016; 48:54–60.

4. Walsh JC, Pozniak AL, Nelson MR, Mandalia S, Gazzard BG. Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance. J Acquir Immune Defic Syndr. 2002; 30:278–287.

5. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000; 12:255–266.

6. Park Y, Seo MJ, Kim S, Park SY. Experience of treatment adherence in Korean patients with HIV. J Korean Acad Nurs. 2014; 44:407–417.

7. Choi JY, Park YS, Kim CO, Park YS, Yoon HJ, Shin SY, Kim YA, Song YG, Kim JM. Correlation between adherence to antiretroviral treatment and virologic failure in HIV-infected Koreans. Infect Chemother. 2005; 37:9–15.

8. Kim MJ, Kim SW, Chang HH, Kim Y, Jin S, Jung H, Park JH, Kim S, Lee JM. Comparison of antiretroviral regimens: adverse effects and tolerability failure that cause regimen switching. Infect Chemother. 2015; 47:231–238.

9. Fong OW, Ho CF, Fung LY, Lee FK, Tse WH, Yuen CY, Sin KP, Wong KH. Determinants of adherence to highly active antiretroviral therapy (HAART) in Chinese HIV/AIDS patients. HIV Med. 2003; 4:133–138.

10. Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodríguez E, Warren MR, Vejo J. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behav. 2011; 15:1381–1396.

11. Reynolds NR, Testa MA, Marc LG, Chesney MA, Neidig JL, Smith SR, Vella S, Robbins GK. Protocol Teams of ACTG 384, ACTG 731 and A5031s. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study. AIDS Behav. 2004; 8:141–150.

12. Barfod TS, Sørensen HT, Nielsen H, Rodkjaer L, Obel N. ‘Simply forgot’ is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence. HIV Med. 2006; 7:285–290.

13. Maggiolo F, Ripamonti D, Arici C, Gregis G, Quinzan G, Camacho GA, Ravasio L, Suter F. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients. HIV Clin Trials. 2002; 3:371–378.

14. Stout BD, Leon MP, Niccolai LM. Nonadherence to antiretroviral therapy in HIV-positive patients in Costa Rica. AIDS Patient Care STDS. 2004; 18:297–304.

15. Molassiotis A, Nahas-Lopez V, Chung WY, Lam SW, Li CK, Lau TF. Factors associated with adherence to antiretroviral medication in HIV-infected patients. Int J STD AIDS. 2002; 13:301–310.

16. Cambiano V, Lampe FC, Rodger AJ, Smith CJ, Geretti AM, Lodwick RK, Puradiredja DI, Johnson M, Swaden L, Phillips AN. Long-term trends in adherence to antiretroviral therapy from start of HAART. AIDS. 2010; 24:1153–1162.